EU Launches Antitrust Probe Over Lundbeck Drug
The European Commission has opened a formal antitrust investigation into Danish drugmaker H. Lundbeck A/S, principally examining whether the company has restricted the entry of a generic version of its antidepressant...To view the full article, register now.
Already a subscriber? Click here to view full article